EP290/#820  Intermittent PARP inhibitor regimen in ovarian cancer (IPIROC): origin and feasibility of implementing a proof-of-concept exploratory study

Asima Mukhopadhyay; Tanushri Ghosh; Daity Bhattacharjee; Dona Chakraborty; Rama Gupta; Indrani Roychowdhury; Puja Chatterjee; Manisha Vernekar; Rahul Roy Chowdhury; Ipiroc Study Group

doi:10.1136/ijgc-2023-IGCS.357

Article info

ePoster Viewing

AS11. Ovarian cancer

EP290/#820 Intermittent PARP inhibitor regimen in ovarian cancer (IPIROC): origin and feasibility of implementing a proof-of-concept exploratory study

Free

Authors

Asima Mukhopadhyay Kolkata Gynecological Oncology Trials and Translational Research Group, Gynecological Oncology, Kolkata, India Newcastle University, Population Health Sciences Institute, Newcastle, UK PubMed articles Google scholar articles
Tanushri Ghosh Kolkata Gynecological Oncology Trials and Translational Research Group, Gynecological Oncology, Kolkata, India PubMed articles Google scholar articles
Daity Bhattacharjee Kolkata Gynecological Oncology Trials and Translational Research Group, Gynecological Oncology, Kolkata, India PubMed articles Google scholar articles
Dona Chakraborty Kolkata Gynecological Oncology Trials and Translational Research Group, Gynecological Oncology, Kolkata, India PubMed articles Google scholar articles
Rama Gupta Kolkata Gynecological Oncology Trials and Translational Research Group, Gynecological Oncology, Kolkata, India PubMed articles Google scholar articles
Indrani Roychowdhury Jawaharlal Nehru University, Economics, New Delhi, India PubMed articles Google scholar articles
Puja Chatterjee Chittaranjan National Cancer Institute, Gynecological Oncology, Kolkata, India PubMed articles Google scholar articles
Manisha Vernekar Chittaranjan National Cancer Institute, Gynecological Oncology, Kolkata, India PubMed articles Google scholar articles
Rahul Roy Chowdhury Saroj Gupta Cancer Centre and Research Institute, Gynecological Oncology, Kolkata, India PubMed articles Google scholar articles
Ipiroc Study Group Kolkata Gynecological Oncology Trials and Translational Research Group, Gynecological Oncology, Kolkata, India PubMed articles Google scholar articles

Citation

Mukhopadhyay A, Ghosh T, Bhattacharjee D, et al

EP290/#820 Intermittent PARP inhibitor regimen in ovarian cancer (IPIROC): origin and feasibility of implementing a proof-of-concept exploratory study

International Journal of Gynecologic Cancer 2023;33:A197-A198.

Publication history

First published November 7, 2023.

Online issue publication

November 07, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password